Difference between revisions of "About-cancer/treatment/drugs/soft-tissue-sarcoma"
Jump to navigation
Jump to search
(Created page with "== Drugs Approved for Soft Tissue Sarcoma == This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. The list includes generi...") |
|||
| Line 1: | Line 1: | ||
| + | <languages/> | ||
| + | <translate> | ||
== Drugs Approved for Soft Tissue Sarcoma == | == Drugs Approved for Soft Tissue Sarcoma == | ||
| Line 36: | Line 38: | ||
VAC | VAC | ||
| + | </translate> | ||
Revision as of 18:37, 28 October 2019
Drugs Approved for Soft Tissue Sarcoma
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for soft tissue sarcoma. The list includes generic names and brand names. The drug names link to NCI's Cancer Drug Information summaries. There may be drugs used in soft tissue sarcoma that are not listed here.
ON THIS PAGE
- Drugs Approved for Soft Tissue Sarcoma
- Drug Combinations Used in Soft Tissue Sarcoma
Drugs Approved for Soft Tissue Sarcoma
Cosmegen (Dactinomycin)
Dactinomycin
Doxorubicin Hydrochloride
Eribulin Mesylate
Gleevec (Imatinib Mesylate)
Halaven (Eribulin Mesylate)
Imatinib Mesylate
Pazopanib Hydrochloride
Trabectedin
Votrient (Pazopanib Hydrochloride)
Yondelis (Trabectedin)
Drug Combinations Used in Soft Tissue Sarcoma
VAC
